Scarica l'app Stockscreener
0.4596
0.35%
-0.0016
Pre-mercato:
.45
-0.0096
-2.09%
Precedente Chiudi:
$0.4612
Aprire:
$0.4655
Volume 24 ore:
1.36M
Relative Volume:
0.10
Capitalizzazione di mercato:
$67.73M
Reddito:
-
Utile/perdita netta:
$-54.17M
Rapporto P/E:
-1.2425
EPS:
-0.3699
Flusso di cassa netto:
$-39.34M
1 W Prestazione:
-5.70%
1M Prestazione:
+27.14%
6M Prestazione:
-73.59%
1 anno Prestazione:
-81.54%
Intervallo 1D:
$0.454
$0.4698
Intervallo di 1 settimana:
$0.427
$0.489
Portata 52W:
$0.2928
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Nome
Immutep Limited Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare IMMP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.4596 | 67.73M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-13 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | Downgrade | Maxim Group | Buy → Hold |
| 2026-03-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | Iniziato | Citizens | Mkt Outperform |
| 2024-05-17 | Iniziato | CapitalOne | Overweight |
| 2023-08-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-07-16 | Ripresa | Maxim Group | Buy |
| 2018-09-28 | Iniziato | B. Riley FBR | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
Mostra tutto
Immutep Limited Adr Borsa (IMMP) Ultime notizie
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - ChartMill
IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
IMMP Forecast, Price Target & Analyst Ratings | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
ROSEN, A LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
ROSEN, LEADING INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - ChartMill
Immutep LTD ADR (IMMP) News, Articles, Events & Latest Updates - Stocktwits
IMMP Investor Alert: Immutep Ltd. Securities Fraud InvestigationInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Failed To Disclose Material Risks Related To Trial Viability : Levi & Korsinsky - Sahm
Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings - Sahm
Dow Gains 100 Points; Bank of America Earnings Top Views - Sahm
US Market Preview | IMMP Surges 200%; Trump on Iran War: 'Close to Over'; Tesla AI5 Chip Tapped Out; ASML Falls 3% After Weak Q2 Outlook - Sahm
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15% - Investing.com
These stocks are moving in today's session - ChartMill
Which stocks are most active on Wednesday? - ChartMill
Here are the top movers in Wednesday's session. - ChartMill
These stocks are moving in today's pre-market session - ChartMill
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma - ChartMill
Working capital per share of Immutep Ltd Sponsored ADR – FWB:YP1A - TradingView — Track All Markets
IMMP Investor News: If You Have Suffered Losses in Immutep - GlobeNewswire
ROSEN, A NATIONALLY RECOGNIZED INVESTOR RIGHTS LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
POM IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
IMMP Investors Have Opportunity to Join Immutep Limited Fraud Investigation with the Schall Law Firm - Business Wire
Immutep (NASDAQ: IMMP) reports positive Phase I progress for LAG-3 agonist IMP761 - Stock Titan
On Wednesday, there are stocks with unusual volume. Let's take a look. - ChartMill
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Immutep Limited (IMMP) And Encourages Investors to Reach Out - accessnewswire.com
Immutep Limited Adr Azioni (IMMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):